This can be a big boost to pfi

2022-02-13

This can be a big boost to pfizer.

I am bit concerned that pfizer stock is not taking the advantage panademic business opportunity.

China Approves Use of Pfizer's COVID Drug Paxlovid

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

CyrilDavy
2022-02-13
CyrilDavy
Rocketship about to take off next monday,prepare for a massive rally to $70. Load up more at this cheap prices!
KittyBruno
2022-02-13
KittyBruno
Just because Pfizer does some good things, we can't let them get away with the REALLY bad things they also do...
MatthewWalter
2022-02-13
MatthewWalter
Right now the whole market is bleeding except oil. But I do believe pfe, though it was not Incrased as moderna and biontech in the last year
FranklinMorley
2022-02-13
FranklinMorley
Pandemic is almost over. Pfizer shares have no reason to stay as high as they are. Time to sell.
LeilaLynch
2022-02-13
LeilaLynch
Sales of Feb and March 55 and 60 usd PFE Calls are going through the roof. Is the bottom reached?

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":9092497402,"tweetId":"9092497402","gmtCreate":1644709574556,"gmtModify":1676533953977,"author":{"id":3575011341539105,"idStr":"3575011341539105","authorId":3575011341539105,"authorIdStr":"3575011341539105","name":"kuppi","avatar":"https://static.tigerbbs.com/1a1c96e4fc6f6f67de0450751c853214","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":151,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>This can be a big boost to pfizer.</p><p>I am bit concerned that pfizer stock is not taking the advantage panademic business opportunity.</p></body></html>","htmlText":"<html><head></head><body><p>This can be a big boost to pfizer.</p><p>I am bit concerned that pfizer stock is not taking the advantage panademic business opportunity.</p></body></html>","text":"This can be a big boost to pfizer. I am bit concerned that pfizer stock is not taking the advantage panademic business opportunity.","highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9092497402","repostId":2210409526,"repostType":4,"repost":{"id":"2210409526","kind":"news","pubTimestamp":1644633920,"share":"https://www.laohu8.com/m/news/2210409526?lang=&edition=full","pubTime":"2022-02-12 10:45","market":"us","language":"en","title":"China Approves Use of Pfizer's COVID Drug Paxlovid","url":"https://stock-news.laohu8.com/highlight/detail?id=2210409526","media":"Reuters","summary":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditi","content":"<html><head></head><body><p>BEIJING, Feb 12 (Reuters) - China&#39;s medical products regulator said on Saturday it has given conditional approval for Pfizer&#39;s COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.</p><p>The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.</p><p>It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. </p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Approves Use of Pfizer's COVID Drug Paxlovid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Approves Use of Pfizer's COVID Drug Paxlovid\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-12 10:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4124":"机动车零配件与设备","BK4534":"瑞士信贷持仓","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2210409526","content_text":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":157,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":109,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":100517789,"commentId":"100517789","gmtCreate":1644717902916,"gmtModify":1663243705141,"authorId":9000000000000641,"author":{"id":9000000000000641,"idStr":"9000000000000641","authorId":9000000000000641,"name":"CyrilDavy","avatar":"https://static.tigerbbs.com/fd67ba4a6ca5ca66b27af6afcce989dc","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9092497402,"objectIdStr":"9092497402","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Rocketship about to take off next monday,prepare for a massive rally to $70. Load up more at this cheap prices!","text":"Rocketship about to take off next monday,prepare for a massive rally to $70. Load up more at this cheap prices!","html":"Rocketship about to take off next monday,prepare for a massive rally to $70. Load up more at this cheap prices!","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":100517782,"commentId":"100517782","gmtCreate":1644717876620,"gmtModify":1663243705243,"authorId":9000000000000521,"author":{"id":9000000000000521,"idStr":"9000000000000521","authorId":9000000000000521,"name":"KittyBruno","avatar":"https://static.tigerbbs.com/55e526bf56359c8153d15df97d3245b8","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9092497402,"objectIdStr":"9092497402","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Just because Pfizer does some good things, we can't let them get away with the REALLY bad things they also do...","text":"Just because Pfizer does some good things, we can't let them get away with the REALLY bad things they also do...","html":"Just because Pfizer does some good things, we can't let them get away with the REALLY bad things they also do...","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":100517764,"commentId":"100517764","gmtCreate":1644717817972,"gmtModify":1663243705038,"authorId":9000000000000488,"author":{"id":9000000000000488,"idStr":"9000000000000488","authorId":9000000000000488,"name":"MatthewWalter","avatar":"https://static.tigerbbs.com/673f24849e790c3aa318f19aa443d828","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9092497402,"objectIdStr":"9092497402","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Right now the whole market is bleeding except oil. But I do believe pfe, though it was not Incrased as moderna and biontech in the last year","text":"Right now the whole market is bleeding except oil. But I do believe pfe, though it was not Incrased as moderna and biontech in the last year","html":"Right now the whole market is bleeding except oil. But I do believe pfe, though it was not Incrased as moderna and biontech in the last year","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":100517824,"commentId":"100517824","gmtCreate":1644718088695,"gmtModify":1663243704940,"authorId":9000000000000584,"author":{"id":9000000000000584,"idStr":"9000000000000584","authorId":9000000000000584,"name":"FranklinMorley","avatar":"https://static.tigerbbs.com/41438e43bc06f3d850c94c7d80eb56cf","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9092497402,"objectIdStr":"9092497402","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Pandemic is almost over. Pfizer shares have no reason to stay as high as they are. Time to sell.","text":"Pandemic is almost over. Pfizer shares have no reason to stay as high as they are. Time to sell.","html":"Pandemic is almost over. Pfizer shares have no reason to stay as high as they are. Time to sell.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":100517794,"commentId":"100517794","gmtCreate":1644717942431,"gmtModify":1644717942431,"authorId":9000000000000513,"author":{"id":9000000000000513,"idStr":"9000000000000513","authorId":9000000000000513,"name":"LeilaLynch","avatar":"https://static.tigerbbs.com/e32612860d02f31ae6eb923f14c61b63","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9092497402,"objectIdStr":"9092497402","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Sales of Feb and March 55 and 60 usd PFE Calls are going through the roof. Is the bottom reached?","text":"Sales of Feb and March 55 and 60 usd PFE Calls are going through the roof. Is the bottom reached?","html":"Sales of Feb and March 55 and 60 usd PFE Calls are going through the roof. Is the bottom reached?","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/9092497402"}